BioCryst Pharmaceuticals
BCRX
BCRX
109 hedge funds and large institutions have $156M invested in BioCryst Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 26 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
76% less capital invested
Capital invested by funds: $650M → $156M (-$494M)
Holders
109
Holding in Top 10
1
Calls
$167K
Puts
$92K
Top Buyers
| 1 | +$13.3M | |
| 2 | +$4.21M | |
| 3 | +$2.24M | |
| 4 |
VM
VHCP Management
New York
|
+$1.59M |
| 5 |
SIM
Spark Investment Management
New York
|
+$1.25M |
Top Sellers
| 1 | -$18.4M | |
| 2 | -$16.9M | |
| 3 | -$14M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$11.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$7.74M |